Literature DB >> 30058526

Medicine-based evidence: the case of antidepressants in patients with coronary artery disease.

C Barbui1, G Ostuzzi1.   

Abstract

In individuals with coronary artery disease and concurrent depressive symptomatology, the evidence on the beneficial and harmful effects of antidepressants is very limited. Recently, a study was carried out to describe depressive symptoms and the treatments provided under real-world circumstances to cardiac patients who entered the Mayo Clinic cardiac rehabilitation program. Antidepressant use was associated with reductions in depressive symptoms, but also with poorer cardiovascular outcomes. In this commentary, the results of this study are discussed in view of their clinical implications for everyday clinical practice and for the production of knowledge.

Entities:  

Keywords:  Adverse effects; antidepressants; chronic conditions; psychopharmacology

Mesh:

Substances:

Year:  2018        PMID: 30058526      PMCID: PMC6998947          DOI: 10.1017/S2045796018000380

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  16 in total

1.  Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

Authors:  Ellyn M Johnson; Ellen Whyte; Benoit H Mulsant; Bruce G Pollock; Elizabeth Weber; Amy E Begley; Charles F Reynolds
Journal:  Am J Geriatr Psychiatry       Date:  2006-09       Impact factor: 4.105

2.  Bleeding induced by SSRIs.

Authors:  M E Ceylan; M H Alpsan-Omay
Journal:  Eur Psychiatry       Date:  2005-12       Impact factor: 5.361

3.  Evidence, knowledge, implementation: glossary of terminology.

Authors:  C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-19       Impact factor: 6.892

4.  Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.

Authors:  M Nosè; I Bighelli; M Castellazzi; G Martinotti; G Carrà; C Lucii; G Ostuzzi; F Sozzi; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2015-10-15       Impact factor: 6.892

5.  Public health psychopharmacology: a new research discipline comes of age?

Authors:  C Barbui; G Ostuzzi; B Godman
Journal:  Epidemiol Psychiatr Sci       Date:  2018-02       Impact factor: 6.892

Review 6.  Prevalence of depression in survivors of acute myocardial infarction.

Authors:  Brett D Thombs; Eric B Bass; Daniel E Ford; Kerry J Stewart; Konstantinos K Tsilidis; Udita Patel; James A Fauerbach; David E Bush; Roy C Ziegelstein
Journal:  J Gen Intern Med       Date:  2006-01       Impact factor: 5.128

7.  Self-reported depressive symptoms, diagnosed clinical depression and cardiac morbidity and mortality after myocardial infarction.

Authors:  Marij Zuidersma; Henk Jan Conradi; Joost P van Melle; Johan Ormel; Peter de Jonge
Journal:  Int J Cardiol       Date:  2012-07-24       Impact factor: 4.164

8.  Do antidepressants prolong the QT interval?

Authors:  M Nosè; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2014-03       Impact factor: 6.892

9.  Clinical databases of patients receiving antidepressants. The missing link between research and practice?

Authors:  Corrado Barbui; Gianni Tognoni; Silvio Garattini
Journal:  J Affect Disord       Date:  2002-07       Impact factor: 4.839

10.  Depression and the Risk of Myocardial Infarction and Coronary Death: A Meta-Analysis of Prospective Cohort Studies.

Authors:  Qing Wu; Juliana M Kling
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.